rupatadine has been researched along with Electrocardiogram QT Prolonged in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ferber, G; Fernandes, S; Izquierdo, I; Santamaría, E; Täubel, J | 1 |
Fité-Mora, R | 1 |
1 trial(s) available for rupatadine and Electrocardiogram QT Prolonged
Article | Year |
---|---|
Cardiac Safety of Rupatadine in a Single-Ascending-Dose and Multiple-Ascending-Dose Study in Healthy Japanese Subjects, Using Intensive Electrocardiogram Assessments-Comparison With the Previous White Caucasian Thorough QT Study.
Topics: Asian People; Cyproheptadine; Double-Blind Method; Electrocardiography; Food-Drug Interactions; Healthy Volunteers; Heart Rate; Humans; Long QT Syndrome; White People | 2018 |
1 other study(ies) available for rupatadine and Electrocardiogram QT Prolonged
Article | Year |
---|---|
Torsade de pointes associated with rupatadine.
Topics: Cyproheptadine; Histamine H1 Antagonists; Humans; Long QT Syndrome; Platelet Activating Factor; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Spain; Torsades de Pointes | 2009 |